Tricin Pharmaceutical

Tricin Pharmaceutical is a biotechnology company focused on the development of therapeutic agents derived from tricin, a natural flavone found in cereal grains and herbaceous plants. The company leverages the multi-functional properties of tricin, including its anti-inflammatory, anti-allergic, and anti-tumor activities, to target a variety of conditions such as KRAS-mutated lung cancer and inflammatory disorders. Their research highlights tricin's ability to modulate key signaling pathways like TLR4/NF-κB and inhibit enzymes such as CDK9 and tyrosinase. Currently, the company's programs are primarily in the pre-clinical stage, with a strong emphasis on isolating and characterizing novel tricin derivatives for pharmaceutical and cosmeceutical applications.